The Role of the Innate Immune System in Cancer Dormancy and Relapse

Area of Science:

• Oncology
• Immunology
• Cancer Metastasis

Background:

• Therapy failure in cancer is often linked to metastatic spread and recurrence.
• Cancer cells can disseminate early, remain dormant for years, and reactivate, posing a significant clinical challenge.
• The tumor microenvironment, including stromal and immune cells, influences cancer cell dormancy and reactivation.

Purpose of the Study:

• To review the journey of metastatic cells from dissemination to recurrence.
• To emphasize the role of the innate immune system in cancer cell dormancy and reactivation.
• To highlight knowledge gaps in understanding immune cell interactions with cancer cells during metastasis and dormancy.

Main Methods:

• Literature review focusing on cancer cell metastasis, dormancy, and recurrence.
• Emphasis on the role of the innate immune system in these processes.
• Analysis of interactions between cancer cells and immune/stromal cells in the metastatic niche.

Main Results:

• Innate immune cells can be co-opted by primary tumors to facilitate cancer cell dissemination and dormancy.
• Specific mechanisms regulating metastasis and dormancy in the context of anti-tumor immunity are largely unknown.
• Interactions within the metastatic niche dictate dormancy length and reactivation timing.

Conclusions:

• Further research into immune cell-cancer cell interactions is crucial for understanding metastasis and dormancy.
• Targeting the reactivation of dormant cancer cells offers a potential therapeutic strategy.
• New therapies could be developed by targeting immune cell roles in cancer progression and recurrence.